Keyword Connections

rituximab

Journals

5

1 human gene therapy

2 therapeutic advances in neurological disorders

3 hematological oncology

4 international journal of hematology

5 Hematology (Amsterdam, Netherlands)

Research Groups

0

No Research Group Connected

Bibliographies

36

1 Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.

2 Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.

3 rituximab-containing treatment regimens may imply a long-term risk for difficult-to-treat chronic hepatitis e

4 hemofilia a adquirida acquired hemophilia a

5 enhanced international prognostic index in japanese patients with diffuse large b-cell lymphoma

6 severe liver damage and nonallergic bronchitis with eosinophilia in a patient with follicular lymphoma treated with bendamustine plus rituximab

7 Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis

8 Characteristic features of primary testicular lymphoma and survival trends: a multicenter clinical study.

9 Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab

10 Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome

11 Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab

12 Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma.

13 Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

14 Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.

15 Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in Germany.

16 Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

17 Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial

18 First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial

19 Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease

20 Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study

21 real word evidence on rituximab utilization: combining administrative and hospital-pharmacy data.

22 the evaluation and optimal use of rituximab in lymphoid malignancies

23 improvement of paraneoplastic limbic encephalitis after systemic treatment with rituximab in a patient with b-cell chronic lymphocytic leukemia

24 rituximab not effective for hearing loss in cogan’s syndrome

25 successful outcome of a corticodependent henoch-schönlein purpura adult with rituximab

26 rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy

27 response of paroxysmal nocturnal hemoglobinuria clone with aplastic anemia to rituximab

28 combination immunosuppressive therapy including rituximab for epstein-barr virus-associated hemophagocytic lymphohistiocytosis in adult-onset still’s disease

29 fe de errores de "evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica" erratum to "economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia"

30 idiopathic relapsing thrombotic thrombocytopenic purpura with persistent adamts13 inhibitor activity treated sequentially with plasmapheresis, rituximab, cyclophosphamide and splenectomy

31 long-term remission of primary bone marrow diffuse large b-cell lymphoma treated with high-dose chemotherapy rescued by in vivo rituximab-purged autologous stem cells

32 granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide

33 mitomycin-c-induced ttp/hus treated successfully with rituximab: case report and review of the literature

34 safety of rituximab in rheumatoid arthritis

35 Pentostatin, Cyclophosphamide and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E2903)

36 [Clinical Efficiency of Rituximab Combined with Autologous Hematopoietic Blood Stem Cell Transplantation for Treatment of CD20 B non.Hodgkin Lymphoma].